CAXTON CORP - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 108 filers reported holding KURA ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 11.49 and the average weighting 0.5%.

Quarter-by-quarter ownership
CAXTON CORP ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q2 2020$333,000
+50.0%
20,406
-8.5%
0.35%
+44.4%
Q1 2020$222,000
-27.7%
22,302
+0.0%
0.24%
-17.9%
Q4 2019$307,000
-35.9%
22,295
-29.4%
0.30%
-45.2%
Q3 2019$479,000
-11.3%
31,567
+15.2%
0.54%
-11.9%
Q2 2019$540,000
+68.8%
27,402
+42.2%
0.61%
+106.4%
Q1 2019$320,000
-30.6%
19,274
-41.3%
0.30%
-46.9%
Q4 2018$461,000
-24.1%
32,828
-5.4%
0.56%
-0.4%
Q3 2018$607,000
+103.0%
34,708
+111.4%
0.56%
+429.2%
Q2 2018$299,00016,4150.11%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2018
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders